A comprehensive review on traditional uses, phytochemistry and pharmacological properties of Paeonia emodi Wall. ex Royle: current landscape and future perspectives.

Nida Zahra, Javed Iqbal, Muhammad Arif, Banzeer Ahsan Abbasi, Hassan Sher, Ayesha Fazal Nawaz, Tabassum Yaseen, Alibek Ydyrys, Javad Sharifi-Rad, Daniela Calina
Author Information
  1. Nida Zahra: Department of Biotechnology, University of Mianwali, Mianwali, 42200, Pakistan.
  2. Javed Iqbal: Department of Botany, Bacha Khan University, Charsadda, Khyber Pakhtunkhwa, Pakistan. javed89qau@gmail.com.
  3. Muhammad Arif: Department of Biotechnology, University of Mianwali, Mianwali, 42200, Pakistan.
  4. Banzeer Ahsan Abbasi: Department of Botany, Rawalpindi Women University, 6th Road, Satellite Town, Rawalpindi, 46300, Pakistan.
  5. Hassan Sher: Center for Plant Sciences and Biodiversity, University of Swat, Kanju, 19201, Pakistan.
  6. Ayesha Fazal Nawaz: National Institute of Genomics and Advanced Biotechnology (NIGAB), National Agricultural Research Center (NARC), Park Road, Islamabad, Pakistan.
  7. Tabassum Yaseen: Department of Botany, Bacha Khan University, Charsadda, Khyber Pakhtunkhwa, Pakistan.
  8. Alibek Ydyrys: Biomedical Research Centre, Al-Farabi Kazakh National University, Al-Farabi Ave. 71, 050040, Almaty, Kazakhstan.
  9. Javad Sharifi-Rad: Facultad de Medicina, Universidad del Azuay, Cuenca, Ecuador. javad.sharifirad@gmail.com. ORCID
  10. Daniela Calina: Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania. calinadaniela@gmail.com.

Abstract

Paeonia emodi Wall. ex Royle is commonly known as Himalayan paeony has great importance as a food and medicine. The practice of Paeonia emodi Wall. ex Royle is very ancient and it is conventionally used for a wide range of illnesses in the folk system of medicine because of its wide beneficial phytochemical profile. The main purpose of the current review was the synthesis of recent data on botany, ethnopharmacology, phytochemistry and potential pharmacological mechanisms of action of Paeonia emodi Wall. ex Royle, thus offering new prospects for the development of new adjuvant natural therapies. Using scientific databases such as PubMed/MedLine, Scopus, Web of Science, ScienceDirect, Google Scholar, Springer, and Wiley, a comprehensive literature search was performed for Paeonia emodi Wall. ex Royle. For searching, we used the next MeSH terms: "Biological Product/isolation and purification", "Biological Products/pharmacology", "Drug Discovery/methods", "Ethnopharmacology, Medicine", "Traditional/methods", "Paeonia/chemistry", "Plant Extracts/pharmacology", "Phytochemicals/chemistry", "Phytochemicals/pharmacology", "Plants, Medicinal". The results of the most recent studies were analyzed and the most important data were summarized in tables and figures. Phytochemical research of Paeonia emodi Wall. ex Royle has led to the isolation of triterpenes, monoterpenes, phenolic acids, fatty acids, organic compounds, steroids, free radicals and some other classes of primary metabolites. In addition, diverse pharmacological activities like antibacterial, antifungal, anticoagulant, airway relaxant lipoxygenase and beta-glucuronidase inhibiting activity, radical scavenging activity, phytotoxic and insecticidal activities have been reported for Paeonia emodi Wall. ex Royle. Different bioactive compounds of Paeonia emodi Wall. ex Royle has proven their therapeutic potential in modern pharmacological and biomedical research to cure numerous gastrointestinal and nervous disorders. In future, further in vitro and in vivo therapeutic studies are required to identify new mechanisms of action, pharmacokinetics studies, and new pharmaceutical formulations for target transport and possible interaction with allopathic drugs. Also, new research regarding quality evaluation, toxicity and safety data in humans is needed.

Keywords

References

  1. Evid Based Complement Alternat Med. 2022 Mar 7;2022:6727609 [PMID: 35295925]
  2. Prog Biomater. 2022 Dec;11(4):321-329 [PMID: 35904711]
  3. Biomed Pharmacother. 2023 Feb;158:114145 [PMID: 36586242]
  4. Exp Ther Med. 2017 May;13(5):2375-2381 [PMID: 28565851]
  5. J Ayurveda Integr Med. 2012 Jan;3(1):29-32 [PMID: 22529677]
  6. J Ethnopharmacol. 2004 Dec;95(2-3):277-84 [PMID: 15507349]
  7. Chin Med. 2021 Apr 17;16(1):33 [PMID: 33865425]
  8. Oxid Med Cell Longev. 2021 Dec 28;2021:1602437 [PMID: 34992714]
  9. Physiol Mol Biol Plants. 2022 Sep;28(9):1785-1798 [PMID: 36387977]
  10. J Ethnopharmacol. 2020 Aug 10;258:112913 [PMID: 32371143]
  11. Oxid Med Cell Longev. 2022 Feb 4;2022:6025900 [PMID: 35154569]
  12. J Ayurveda Integr Med. 2010 Oct;1(4):287-91 [PMID: 21731376]
  13. Front Pharmacol. 2020 Aug 26;11:1300 [PMID: 32982731]
  14. Phytother Res. 2004 Aug;18(8):670-3 [PMID: 15476301]
  15. Front Oncol. 2023 Jan 09;12:1068778 [PMID: 36698404]
  16. Food Chem Toxicol. 2020 Jan;135:111038 [PMID: 31825855]
  17. J Pers Med. 2022 Sep 15;12(9): [PMID: 36143299]
  18. J Ethnopharmacol. 2011 Jan 27;133(2):378-95 [PMID: 20950680]
  19. Altern Med Rev. 2009 Dec;14(4):380-4 [PMID: 20030464]
  20. Phytomedicine. 1995 Jul;2(1):51-5 [PMID: 23196101]
  21. J Ethnopharmacol. 2000 Aug;71(3):411-23 [PMID: 10940578]
  22. Biomolecules. 2018 Dec 23;9(1): [PMID: 30583611]
  23. Oxid Med Cell Longev. 2022 Feb 14;2022:8214821 [PMID: 35198096]
  24. Exp Toxicol Pathol. 2013 Jan;65(1-2):135-41 [PMID: 21852078]
  25. Chin Med. 2021 Aug 6;16(1):72 [PMID: 34362401]
  26. ISRN Pharmacol. 2014 Mar 10;2014:182362 [PMID: 24734192]
  27. Chin Med. 2022 Sep 29;17(1):114 [PMID: 36175969]
  28. Biomed Pharmacother. 2022 Oct;154:113555 [PMID: 36027610]
  29. J Ethnopharmacol. 1990 Aug;30(1):55-73 [PMID: 2214824]
  30. Chin J Integr Med. 2022 Mar;28(3):249-256 [PMID: 34913151]
  31. Cancer Cell Int. 2022 Oct 7;22(1):305 [PMID: 36207736]
  32. Cancer Cell Int. 2022 Jul 28;22(1):239 [PMID: 35902860]
  33. J Ethnopharmacol. 2011 Sep 1;137(1):27-35 [PMID: 21335083]
  34. Chem Pharm Bull (Tokyo). 2003 Mar;51(3):252-4 [PMID: 12612406]
  35. J Ethnopharmacol. 2009 Mar 18;122(2):333-62 [PMID: 19146943]
  36. Front Pharmacol. 2020 Oct 22;11:571459 [PMID: 33192514]
  37. Cancer Cell Int. 2022 Nov 15;22(1):354 [PMID: 36376956]
  38. Oxid Med Cell Longev. 2021 Oct 18;2021:3687700 [PMID: 34707776]
  39. Biomed Pharmacother. 2023 Apr;160:114332 [PMID: 36736282]
  40. Cancer Cell Int. 2022 Dec 13;22(1):407 [PMID: 36514100]
  41. Zhonghua Yi Shi Za Zhi. 2010 Nov;40(6):376-8 [PMID: 21223711]
  42. Microbiol Res. 2007;162(3):264-75 [PMID: 16875811]
  43. Respir Res. 2020 Feb 3;21(1):39 [PMID: 32014006]
  44. J Ethnopharmacol. 2019 Mar 1;231:57-65 [PMID: 30391709]
  45. J Nat Prod. 2009 Sep;72(9):1579-84 [PMID: 19691309]
  46. J Ethnopharmacol. 2011 Dec 8;138(3):676-82 [PMID: 21959184]
  47. Int J Mol Med. 2021 Nov;48(5): [PMID: 34515324]
  48. J Pers Med. 2022 Feb 09;12(2): [PMID: 35207733]
  49. Sci Rep. 2021 Jul 19;11(1):14643 [PMID: 34282194]
  50. J Food Drug Anal. 2017 Jul;25(3):576-588 [PMID: 28911644]
  51. J Clin Med. 2020 Apr 29;9(5): [PMID: 32365529]
  52. Oxid Med Cell Longev. 2022 May 29;2022:1035441 [PMID: 35677108]
  53. J Ethnopharmacol. 1995 Apr;46(1):17-23 [PMID: 7475119]
  54. Front Pharmacol. 2021 May 11;12:600139 [PMID: 34045956]
  55. J Oncol. 2021 Dec 10;2021:5905357 [PMID: 34925509]
  56. Chin Med. 2021 Aug 23;16(1):83 [PMID: 34425861]
  57. Biomedicines. 2020 May 15;8(5): [PMID: 32429264]
  58. J Ethnobiol Ethnomed. 2014 Apr 16;10:36 [PMID: 24739524]
  59. Exp Parasitol. 2011 Oct;129(2):211-4 [PMID: 21782813]
  60. Front Pharmacol. 2021 Jan 14;11:578823 [PMID: 33628170]
  61. Exp Ther Med. 2016 Oct;12(4):2078-2082 [PMID: 27698695]
  62. Ir Vet J. 2014 Mar 01;67(1):6 [PMID: 24580769]
  63. Oxid Med Cell Longev. 2021 Jul 19;2021:3268136 [PMID: 34336089]
  64. Evid Based Complement Alternat Med. 2022 Feb 24;2022:4024331 [PMID: 35251206]
  65. Phytother Res. 2021 Mar;35(3):1187-1217 [PMID: 33025667]
  66. Microsc Res Tech. 2022 Jan;85(1):181-192 [PMID: 34390521]
  67. J Ethnobiol Ethnomed. 2008 May 30;4:15 [PMID: 18510780]
  68. J Clin Med. 2021 Feb 06;10(4): [PMID: 33562115]
  69. Econ Bot. 2012 Dec;66(4):344-356 [PMID: 23293378]
  70. Plants (Basel). 2022 Jul 20;11(14): [PMID: 35890519]
  71. Adv Pharmacol Pharm Sci. 2022 Nov 23;2022:8002766 [PMID: 36465700]
  72. Eur J Med Chem. 2022 Apr 5;233:114217 [PMID: 35276425]
  73. Pak J Pharm Sci. 2012 Jul;25(3):565-9 [PMID: 22713942]
  74. J Ethnopharmacol. 2021 Apr 6;269:113708 [PMID: 33346027]
  75. Dtsch Med Wochenschr. 2008 Feb;133(8):370-1 [PMID: 18270920]
  76. Mol Med Rep. 2017 Dec;16(6):8771-8780 [PMID: 29039613]
  77. Exp Ther Med. 2018 Dec;16(6):4499-4510 [PMID: 30542398]
  78. Mol Med Rep. 2019 Oct;20(4):3701-3708 [PMID: 31485647]
  79. Curr Pharm Des. 2008;14(29):3141-50 [PMID: 19075696]
  80. Molecules. 2016 Oct 13;21(10): [PMID: 27754383]
  81. J Ethnopharmacol. 2018 Jun 28;220:197-219 [PMID: 29625273]
  82. Neurochem Int. 2022 Sep;158:105376 [PMID: 35667491]
  83. J Ethnopharmacol. 2011 Jan 7;133(1):75-85 [PMID: 20837126]
  84. Int J Mol Med. 2019 Jul;44(1):218-226 [PMID: 31115552]
  85. J Pers Med. 2021 May 31;11(6): [PMID: 34072930]
  86. Front Cell Dev Biol. 2022 Sep 29;10:1005910 [PMID: 36247004]
  87. J Ethnopharmacol. 2013 Oct 28;150(1):353-70 [PMID: 24029249]
  88. Can J Physiol Pharmacol. 2008 Nov;86(11):793-803 [PMID: 19011675]
  89. Oxid Med Cell Longev. 2021 Dec 10;2021:6349041 [PMID: 34925698]
  90. Z Naturforsch C J Biosci. 2022 Sep 07;78(1-2):9-25 [PMID: 36069757]
  91. Phytochemistry. 2004 Apr;65(8):1129-35 [PMID: 15110694]
  92. Chin Med. 2022 Nov 4;17(1):125 [PMID: 36333721]
  93. Front Pharmacol. 2022 Sep 15;13:926607 [PMID: 36188551]
  94. Oxid Med Cell Longev. 2022 Jan 19;2022:2910411 [PMID: 35096265]
  95. J Pharm Pharmacol. 2012 Feb;64(2):172-89 [PMID: 22221093]
  96. Anaerobe. 2011 Dec;17(6):399-402 [PMID: 21521657]
  97. Food Sci Nutr. 2023 Jan 13;11(4):1657-1670 [PMID: 37051367]
  98. Neurochem Res. 2021 Sep;46(9):2205-2225 [PMID: 34120291]
  99. J Clin Med. 2020 Jul 27;9(8): [PMID: 32726998]
  100. Chin Med. 2022 Mar 28;17(1):39 [PMID: 35346284]
  101. Chem Pharm Bull (Tokyo). 2000 Nov;48(11):1771-3 [PMID: 11086911]
  102. J Transl Med. 2022 Dec 31;20(1):630 [PMID: 36585670]
  103. J Pharm Anal. 2021 Aug;11(4):398-404 [PMID: 34513116]
  104. J Ethnobiol Ethnomed. 2013 Apr 15;9:25 [PMID: 23587127]
  105. Oxid Med Cell Longev. 2022 Apr 25;2022:8615242 [PMID: 35509838]

Word Cloud

Created with Highcharts 10.0.0PaeoniaemodiWallexRoylenewpharmacologicaldatastudiesresearchactivitiesmedicineusedwidecurrentreviewrecentphytochemistrypotentialmechanismsactioncomprehensive"BiologicalacidscompoundsactivitytherapeuticfutureusescommonlyknownHimalayanpaeonygreatimportancefoodpracticeancientconventionallyrangeillnessesfolksystembeneficialphytochemicalprofilemainpurposesynthesisbotanyethnopharmacologythusofferingprospectsdevelopmentadjuvantnaturaltherapiesUsingscientificdatabasesPubMed/MedLineScopusWebScienceScienceDirectGoogleScholarSpringerWileyliteraturesearchperformedsearchingnextMeSHterms:Product/isolationpurification"Products/pharmacology""DrugDiscovery/methods""EthnopharmacologyMedicine""Traditional/methods""Paeonia/chemistry""PlantExtracts/pharmacology""Phytochemicals/chemistry""Phytochemicals/pharmacology""PlantsMedicinal"resultsanalyzedimportantsummarizedtablesfiguresPhytochemicalledisolationtriterpenesmonoterpenesphenolicfattyorganicsteroidsfreeradicalsclassesprimarymetabolitesadditiondiverselikeantibacterialantifungalanticoagulantairwayrelaxantlipoxygenasebeta-glucuronidaseinhibitingradicalscavengingphytotoxicinsecticidalreportedDifferentbioactiveprovenmodernbiomedicalcurenumerousgastrointestinalnervousdisordersvitrovivorequiredidentifypharmacokineticspharmaceuticalformulationstargettransportpossibleinteractionallopathicdrugsAlsoregardingqualityevaluationtoxicitysafetyhumansneededtraditionalpropertiesRoyle:landscapeperspectivesPharmacologicalPhytochemistryTraditional

Similar Articles

Cited By